Zhou S - Search Results

1

Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Chen X, Sun H, Ren S, Kim Curran V, Zhang L, Zhou S, Zhang J, Zhou C. Chen X, et al. Among authors: zhou s, zhou c. Clin Transl Oncol. 2012 Mar;14(3):207-13. doi: 10.1007/s12094-012-0785-3. Clin Transl Oncol. 2012. PMID: 22374424

2

[Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].

Zhou CC, Zhou SW, Pan H, Su B, Gao ZQ. Zhou CC, et al. Zhonghua Zhong Liu Za Zhi. 2007 Feb;29(2):119-23. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17645848 Chinese.

3

[Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer].

Zhou SW, Ren SX, Yan LH, Zhang L, Zhou CC. Zhou SW, et al. Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):469-72. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19024526 Chinese.

4

Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer.

Zhou S, Ren S, Yan L, Zhang L, Tang L, Zhang J, Zhou C. Zhou S, et al. Among authors: zhou c. Respirology. 2009 Jul;14(5):709-15. doi: 10.1111/j.1440-1843.2009.01564.x. Respirology. 2009. PMID: 19659649 Clinical Trial.

5

BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer.

Li Z, Zhou S, Zhang L, Su C, Hang J, Zhao Y, Su B, Zhou C. Li Z, et al. Among authors: zhou s, zhou c. Med Oncol. 2011 Jun;28(2):572-7. doi: 10.1007/s12032-010-9470-y. Epub 2010 Mar 17. Med Oncol. 2011. PMID: 20237869

6

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, Deng Q, Zhang J. Zhou C, et al. Among authors: zhou s. Jpn J Clin Oncol. 2010 Oct;40(10):954-60. doi: 10.1093/jjco/hyq071. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462983

7

ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer.

Su C, Zhou S, Zhang L, Ren S, Xu J, Zhang J, Lv M, Zhang J, Zhou C. Su C, et al. Among authors: zhou s, zhou c. Med Oncol. 2011 Dec;28(4):1411-7. doi: 10.1007/s12032-010-9553-9. Epub 2010 May 14. Med Oncol. 2011. PMID: 20467918

8

High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.

Ren S, Zhou S, Zhang L, Xu J, Lv M, Zhang J, Zhou C, Zhang J. Ren S, et al. Among authors: zhou s, zhou c. Cancer Invest. 2010 Dec;28(10):1078-83. doi: 10.3109/07357901003735659. Epub 2010 May 26. Cancer Invest. 2010. PMID: 20504223 Clinical Trial.

9

Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.

Su C, Zhou C, Zhou S, Xu J. Su C, et al. Among authors: zhou c, zhou s. Med Oncol. 2011 Dec;28(4):1453-7. doi: 10.1007/s12032-010-9645-6. Epub 2010 Aug 17. Med Oncol. 2011. PMID: 20714944

10

[Relationship between ERCC1 expression and efficacy of neoadjuvant chemotherapy in the patients with non-small-cell lung cancer.].

Zhou S, Zhou C, Xu Q, Yan L. Zhou S, et al. Among authors: zhou c. Zhongguo Fei Ai Za Zhi. 2008 Apr 20;11(2):251-5. doi: 10.3779/j.issn.1009-3419.2008.02.030. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20731911 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,423 results

Search Page

Filters